The International Market Analysis Research and Consulting Group (IMARC Group) has been keeping the top position in terms of provision consultancy services on management strategy and market for above 5 years.
IMARC Group serves customers from diverse industry areas in various regions of the globe by identifying their premium-value biz opps, dealing with their most burning issues, and converting their businesses. The company bears its clients a hand in improving decision-making and strategy-planning processes as well as in moving their business to a higher level.
The reports published by IMARC offer precise information on a slew of industries such as pharmaceutical, high-technology, advanced materials, food and beverage, biotechnology, nanotechnology, tourism and travel and a far more. The reports include detailed market analyses, overviews and forecasts, reviews of the economic and technological developments, profiles of the dominant companies, market/product assessments, etc. IMARC’s research approach unites deep insight into the market dynamics together with strong cooperation with each level of the client organization.
Publications found:
9,055
Sort by:
Alzheimer’s Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2034
US$ 6,499.00
The Alzheimer’s disease market reached a value of US$ 3.1 Billion across the top 7 markets (US, EU4, UK, and Japan) in 2023. Looking forward, IMARC Group expects the top 7 markets to reach US$ 6.3 Bil...
May 2024
140 pages
Chimeric Antigen Receptor (CAR) T-Cell Therapy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major Chimeric Antigen Receptor (CAR) T-Cell Therapy markets reached a value of US$ 3,589.7 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 11,282.5 Million by 2034, e...
May 2024
130 pages
Diffuse Large B-cell Lymphoma (DLBCL) Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major Diffuse Large B-cell Lymphoma (DLBCL) markets reached a value of US$ 3,907.8 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 5,257.7 Million by 2034, exhibiting...
May 2024
132 pages
Idiopathic Pulmonary Fibrosis (IPF) Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2034
US$ 6,499.00
The 7 major Idiopathic Pulmonary Fibrosis (IPF) markets reached a value of US$ 3,586.4 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 6,906.1 Million by 2034, exhibiting a...
May 2024
135 pages
Wet Age-Related Macular Degeneration (Wet AMD) Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major Wet Age-Related Macular Degeneration (Wet AMD) markets reached a value of US$ 8,997.9 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 16,864.9 Million by 2034, e...
May 2024
129 pages
Abdominal Aortic Aneurysm Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major abdominal aortic aneurysm markets reached a value of US$ 1,692.4 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3,235.2 Million by 2034, exhibiting a growth rat...
May 2024
135 pages
Abscess Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major abscess markets reached a value of US$ 869.6 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,253.3 Million by 2034, exhibiting a growth rate (CAGR) of 3.38% du...
May 2024
135 pages
Acute Kidney Injury Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major acute kidney injury markets reached a value of US$ 5,766.5 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 9,904.0 Million by 2034, exhibiting a growth rate (CAG...
May 2024
140 pages
Acute Lymphoblastic Leukemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major acute lymphoblastic leukemia Markets reached a value of US$ 2,145.2 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 4,003.7 Million by 2034, exhibiting a growth...
May 2024
133 pages
Acute Pancreatitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major acute pancreatitis markets reached a value of US$ 695.9 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,062.9 Million by 2034, exhibiting a growth rate (CAGR)...
May 2024
130 pages
Adamantinoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major adamantinoma markets reached a value of US$ 900 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,400 Million by 2034, exhibiting a growth rate (CAGR) of 3.99% d...
May 2024
129 pages
